Remdesivir in moderate to severe COVID-19: A matter of time?

Pharmacol Res. 2021 Aug:170:105711. doi: 10.1016/j.phrs.2021.105711. Epub 2021 Jun 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Alanine / analogs & derivatives
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine